2011

Vigilant Biosciences is a leading innovator and developer of solutions that aid in the early detection and intervention of cancer. Our point-of-care and lab-based solutions are…

Onco-NX Ltd is the University of Salford drug discovery spin-out company, dedicated to the discovery of new promising anticancer agents. We are focused on the development of…

20Med Therapeutics is a Dutch biotechnology company developing innovative solutions for efficient intracellular delivery of (oligo)nucleotide therapeutics (siRNA, miRNA, mRNA,…

ChemomAb is developing therapeutic antibodies for the treatment of autoimmune and inflammatory diseases.

Zhejiang DTRM Biopharma is a biopharmaceutical company that researches and develops new treatments and therapies for cancer and autoimmune diseases.

Remedy Plan is developing the first drugs that halt tumor growth and disrupt the cancer stem cells that cause metastasis.

Tolero is a clinical-stage biopharmaceutical company united by a single purpose: alleviate human suffering through the development of meaningful medicines to treat cancer and other…

Oncorena develops a drug based on the natural substance orellanine, a highly kidney selective toxin from certain mushrooms. The therapeutic concept is to treat patients with…

Blueberry Therapeutics engages in drug discovery and development for the treatments of inflammatory and infectious diseases.

KalVista is focused on the discovery, development and commercialization of small molecule protease inhibitors as new treatments for diseases.